CHLORHEXIDINE Drug Patent Profile
✉ Email this page to a colleague
When do Chlorhexidine patents expire, and what generic alternatives are available?
Chlorhexidine is a drug marketed by Sage Prods, Bajaj, Chartwell Rx, Lyne, Pharm Assoc, Pharmobedient, Sciegen Pharms, Becton Dickinson, and Kendall Il. and is included in ten NDAs. There are two patents protecting this drug.
The generic ingredient in CHLORHEXIDINE is chlorhexidine gluconate. There are fifty-eight drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Chlorhexidine
A generic version of CHLORHEXIDINE was approved as chlorhexidine gluconate by BECTON DICKINSON on October 24th, 1989.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CHLORHEXIDINE?
- What are the global sales for CHLORHEXIDINE?
- What is Average Wholesale Price for CHLORHEXIDINE?
Summary for CHLORHEXIDINE
| US Patents: | 0 |
| Applicants: | 9 |
| NDAs: | 10 |
| Drug Prices: | Drug price information for CHLORHEXIDINE |
| Drug Sales Revenues: | Drug sales revenues for CHLORHEXIDINE |
| DailyMed Link: | CHLORHEXIDINE at DailyMed |
